BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information for the years ended December 31, 2024 and 2023 is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
Asia |
|
Europe |
|
North America |
|
Latin America and Other |
|
Total |
Net sales |
|
$ |
207,794
|
|
|
$ |
84,837
|
|
|
$ |
138,849
|
|
|
$ |
22,884
|
|
|
$ |
454,364
|
|
Cost of sales |
|
48,557
|
|
|
27,836
|
|
|
45,364
|
|
|
7,918
|
|
|
|
Volume incentives |
|
69,685
|
|
|
33,758
|
|
|
29,773
|
|
|
7,374
|
|
|
|
Selling, general and administrative (1) |
|
55,443
|
|
|
18,577
|
|
|
32,793
|
|
|
6,299
|
|
|
|
Segment operating income |
|
$ |
34,109
|
|
|
$ |
4,666
|
|
|
$ |
30,919
|
|
|
$ |
1,293
|
|
|
$ |
70,987
|
|
Unallocated corporate selling, general and administrative expense |
|
|
|
|
|
|
|
|
|
(50,892) |
|
Operating income |
|
|
|
|
|
|
|
|
|
20,095
|
|
Interest and other income, net |
|
|
|
|
|
|
|
|
|
177
|
|
Interest expense |
|
|
|
|
|
|
|
|
|
(146) |
|
Foreign exchange losses, net |
|
|
|
|
|
|
|
|
|
(1,700) |
|
Income from operations before provision for income taxes |
|
|
|
|
|
|
|
|
|
$ |
18,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
Asia |
|
Europe |
|
North America |
|
Latin America and Other |
|
Total |
Net sales |
|
$ |
201,251 |
|
|
$ |
81,101 |
|
|
$ |
139,804 |
|
|
$ |
23,164 |
|
|
$ |
445,320 |
|
Cost of sales |
|
45,373 |
|
|
25,397 |
|
|
45,347 |
|
|
8,076 |
|
|
|
Volume incentives |
|
65,143 |
|
|
33,486 |
|
|
29,392 |
|
|
7,299 |
|
|
|
Selling, general and administrative (1) |
|
60,185 |
|
|
18,434 |
|
|
30,655 |
|
|
6,288 |
|
|
|
Segment operating income |
|
$ |
30,550 |
|
|
$ |
3,784 |
|
|
$ |
34,410 |
|
|
$ |
1,501 |
|
|
$ |
70,245 |
|
Unallocated corporate selling, general and administrative expense |
|
|
|
|
|
|
|
|
|
(51,496) |
|
Operating income |
|
|
|
|
|
|
|
|
|
18,749 |
|
Interest and other income, net |
|
|
|
|
|
|
|
|
|
552 |
|
Interest expense |
|
|
|
|
|
|
|
|
|
(69) |
|
Foreign exchange gains, net |
|
|
|
|
|
|
|
|
|
970 |
|
Income from operations before provision for income taxes |
|
|
|
|
|
|
|
|
|
$ |
20,202 |
|
___________________________
(1) Service fees in China totaled $14.5 million and $16.6 million for the years ended December 31, 2024 and 2023, respectively. These service fees are included in our selling, general and administrative expenses for our Asia segment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2024 |
|
2023 |
Depreciation and amortization: |
|
|
|
|
Asia |
|
$ |
1,876
|
|
|
$ |
1,812 |
|
Europe |
|
93
|
|
|
54 |
|
North America |
|
12,204
|
|
|
9,890 |
|
Latin America and Other |
|
46
|
|
|
60 |
|
Total depreciation and amortization |
|
$ |
14,219
|
|
|
$ |
11,816 |
|
|
Schedule of consolidated net sales revenue by geographical locations |
The table below reflects sales based upon the sales location where they occurred. From an individual country/region perspective, only the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the years ended December 31, 2024 and 2023 as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2024 |
|
2023 |
Net sales: |
|
|
|
|
United States |
|
$ |
127,924
|
|
|
$ |
129,305 |
|
Taiwan |
|
70,579
|
|
|
61,691 |
|
South Korea |
|
51,362
|
|
|
49,845 |
|
Other |
|
204,499
|
|
|
204,479 |
|
Total net sales |
|
$ |
454,364
|
|
|
$ |
445,320 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each product line for the years ended December 31, 2024 and 2023 are as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
Asia |
|
Europe |
|
North America |
|
Latin America and Other |
|
Total |
General health |
|
$ |
81,313 |
|
$ |
36,631 |
|
$ |
59,520 |
|
$ |
6,418 |
|
$ |
183,882 |
Immunity |
|
12,052 |
|
8,454 |
|
15,802 |
|
2,416 |
|
38,724 |
Cardiovascular |
|
56,266 |
|
9,265 |
|
14,443 |
|
1,726 |
|
81,700 |
Digestive |
|
38,958 |
|
22,748 |
|
39,325 |
|
10,713 |
|
111,744 |
Personal care |
|
5,032 |
|
5,397 |
|
6,241 |
|
1,133 |
|
17,803 |
Weight management |
|
14,173 |
|
2,342 |
|
3,518 |
|
478 |
|
20,511 |
Total net sales by segment |
|
$ |
207,794 |
|
$ |
84,837 |
|
$ |
138,849 |
|
$ |
22,884 |
|
$ |
454,364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
Asia |
|
Europe |
|
North America |
|
Latin America and Other |
|
Total |
General health |
|
$ |
69,037 |
|
|
$ |
34,709 |
|
|
$ |
63,742 |
|
|
$ |
6,286 |
|
|
$ |
173,774 |
|
Immunity |
|
5,420 |
|
8,222 |
|
16,124 |
|
2,703 |
|
32,469 |
Cardiovascular |
|
57,771 |
|
9,143 |
|
14,959 |
|
1,718 |
|
83,591 |
Digestive |
|
36,434 |
|
22,111 |
|
34,628 |
|
10,693 |
|
103,866 |
Personal care |
|
5,586 |
|
4,977 |
|
6,476 |
|
1,262 |
|
18,301 |
Weight management |
|
27,003 |
|
1,939 |
|
3,875 |
|
502 |
|
33,319 |
Total net sales by segment |
|
$ |
201,251 |
|
|
$ |
81,101 |
|
|
$ |
139,804 |
|
|
$ |
23,164 |
|
|
$ |
445,320 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States has material balances of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31 |
|
2024 |
|
2023 |
Property, plant and equipment, net |
|
|
|
|
United States |
|
$ |
34,786
|
|
|
$ |
41,239 |
|
Other |
|
4,799
|
|
|
3,761 |
|
Total property, plant and equipment |
|
$ |
39,585
|
|
|
$ |
45,000 |
|
|